Total Payments
$2,107
2024 Payments
$847.21
Companies
32
Transactions
135
Medicare Patients
1,014
Medicare Billing
$48,102
Payment Breakdown by Category
Food & Beverage$2,032 (96.4%)
Education$74.99 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,032 | 134 | 96.4% |
| Education | $74.99 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $250.83 | 31 | $0 (2024) |
| Lilly USA, LLC | $203.83 | 15 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $169.68 | 10 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $153.73 | 8 | $0 (2024) |
| Novo Nordisk Inc | $152.49 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $92.92 | 2 | $0 (2024) |
| Amgen Inc. | $86.85 | 6 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $79.83 | 5 | $0 (2024) |
| Dexcom, Inc. | $74.62 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $72.73 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $847.21 | 41 | Gilead Sciences, Inc. ($92.92) |
| 2023 | $722.69 | 60 | ABBVIE INC. ($150.44) |
| 2022 | $454.93 | 29 | Bayer HealthCare Pharmaceuticals Inc. ($81.27) |
| 2021 | $81.98 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($44.45) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/20/2024 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 09/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| 08/27/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Endocrinology | ||||||
| 07/19/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: ONC | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.93 | General |
| 06/25/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Oncology | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Oncology | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 447 | 773 | $121,003 | $23,190 |
| 2022 | 8 | 396 | 722 | $95,095 | $17,398 |
| 2021 | 6 | 171 | 299 | $36,547 | $7,515 |
Total Patients
1,014
Total Services
1,794
Medicare Billing
$48,102
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 172 | $46,258 | $7,785 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 111 | $42,322 | $7,417 | 17.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $13,136 | $2,801 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $9,231 | $2,410 | 26.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 22 | 25 | $5,525 | $1,356 | 24.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 75 | $675.00 | $630.00 | 93.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 48 | $2,009 | $334.85 | 16.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 20 | $600.00 | $190.40 | 31.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $882.00 | $168.00 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $176.00 | $51.15 | 29.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 14 | $98.00 | $30.80 | 31.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 32 | 239 | $90.82 | $15.86 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 174 | $47,478 | $8,439 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 107 | $41,055 | $7,412 | 18.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 15 | $2,040 | $526.77 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 55 | $2,365 | $443.36 | 18.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 16 | 18 | $1,224 | $279.99 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 54 | 71 | $639.00 | $210.09 | 32.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 23 | 29 | $203.00 | $64.56 | 31.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 37 | 253 | $91.08 | $22.24 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 44 | $17,160 | $3,574 | 20.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 63 | $17,262 | $3,439 | 19.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 24 | 26 | $1,092 | $235.04 | 21.5% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 12 | 12 | $804.00 | $197.16 | 24.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 19 | $171.00 | $57.00 | 33.3% |
About Julie Harmon
Julie Harmon is a Physical Therapist healthcare provider based in Calhoun, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2019. The National Provider Identifier (NPI) number assigned to this provider is 1013474733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Harmon has received a total of $2,107 in payments from pharmaceutical and medical device companies, with $847.21 received in 2024. These payments were reported across 135 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,032).
As a Medicare-enrolled provider, Harmon has provided services to 1,014 Medicare beneficiaries, totaling 1,794 services with total Medicare billing of $48,102. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Therapist
- Other Specialties Physician Assistant
- Location Calhoun, GA
- Active Since 02/28/2019
- Last Updated 07/01/2021
- Taxonomy Code 225100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013474733
Products in Payments
- VRAYLAR (Drug) $218.53
- JARDIANCE (Drug) $169.68
- Kerendia (Drug) $125.80
- Rybelsus (Drug) $93.37
- TRULICITY (Drug) $84.35
- Trodelvy (Drug) $74.99
- Dexcom G6 Transmitter (Medical Supply) $74.62
- MOUNJARO (Drug) $71.23
- Cologuard Collection Kit (Device) $62.23
- VOQUEZNA (Drug) $60.94
- Ozempic (Drug) $59.12
- Otezla (Drug) $56.86
- NURTEC ODT (Drug) $56.53
- FREESTYLE LIBRE 3 (Device) $50.21
- EMGALITY (Drug) $48.25
- GVOKE HYPOPEN (Drug) $47.01
- REXULTI (Drug) $45.60
- TRELEGY ELLIPTA (Drug) $45.27
- Doc Band (Device) $33.87
- GVOKE PFS (Drug) $32.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Therapist Doctors in Calhoun
Julie Mitchell, Pt, PT
Physical Therapist
Physical Therapist
Barbara Marvel, Pt, PT
Physical Therapist
Physical Therapist
Alicia Waltrip, Mpt, MPT
Physical Therapist
Physical Therapist
Douglas Meyer, Pt, PT
Physical Therapist
Physical Therapist
Philip Embry, Pt, PT
Physical Therapist
Physical Therapist
Jennifer Huffman, Dpt, DPT
Physical Therapist
Physical Therapist